Search Results - "Yazdani, Parto"

Effects of the HIV‐1 maturation inhibitor GSK3640254 on QT interval in healthy participants by Zhang, Ying, Bush, Mark, Yazdani, Parto, Zhan, Joyce, Wen, Bo, Bainbridge, Veronica, Wynne, Brian R., Joshi, Samit, Lataillade, Max

“…GSK3640254 (GSK'254) is a novel HIV‐1 maturation inhibitor with pharmacokinetics supporting once‐daily (QD) therapy for HIV‐1 treatment. This thorough…”
Get full text

Open‐label, drug–drug interaction study between the HIV‐1 maturation inhibitor GSK3640254 and a metabolic probe cocktail in healthy participants by Zhang, Ying, Johnson, Mark, Joshi, Samit, Yazdani, Parto, Zhan, Joyce, Wen, Bo, Bainbridge, Veronica, Gartland, Martin, Lataillade, Max

“…Aims GSK3640254 (GSK'254) is an HIV‐1 maturation inhibitor with pharmacokinetics (PK) supporting once‐daily dosing. GSK'254 will be co‐administered with…”
Get full text

Pharmacokinetics and tolerability of the maturation inhibitor GSK3640254 coadministered with darunavir/ritonavir and/or etravirine in healthy adults by Zhang, Ying, Joshi, Samit, Yazdani, Parto, Zhan, Joyce, Wen, Bo, Bainbridge, Veronica, Ballesteros‐Perez, Alex, Gartland, Martin, Lataillade, Max

“…Aims This phase I study investigated potential drug–drug interactions of the maturation inhibitor GSK3640254 (GSK'254) with darunavir/ritonavir (DRV/RTV)…”
Get full text